{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:28Z","timestamp":1792782988233,"version":"4.5.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Science and Technology Strategic Cooperation Programs of Luzhou Municipal People's Government and Southwest Medical University","award":["2024LZXNYDJ089"],"award-info":[{"award-number":["2024LZXNYDJ089"]}]},{"name":"the National Natural Science Foundation of China","award":["82172962"],"award-info":[{"award-number":["82172962"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-026-10227-7","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:47:38Z","timestamp":1784123258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The functions, mechanisms and clinical relevance of RNA and protein acetyltransferase NAT10: a comprehensive review"],"prefix":"10.1007","volume":"42","author":[{"given":"Chengyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengshuang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueshui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9721-4704","authenticated-orcid":false,"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"10227_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2024.102207","author":"C Achour","year":"2024","unstructured":"Achour C, Oberdoerffer S. NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease. Curr Opin Genet Dev. 2024. https:\/\/doi.org\/10.1016\/j.gde.2024.102207.","journal-title":"Curr Opin Genet Dev"},{"key":"10227_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77824-2","author":"W Alam","year":"2020","unstructured":"Alam W, Tayara H, Chong KT. XG-ac4C: identification of N4-acetylcytidine (ac4C) in mRNA using eXtreme gradient boosting with electron-ion interaction pseudopotentials. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-77824-2.","journal-title":"Sci Rep"},{"key":"10227_CR3","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.5c00812","author":"K Ao","year":"2025","unstructured":"Ao K, et al. Targeted NAT10 degradation by PROTAC NP1192 suppresses hypoxia-adaptive glycolysis and reinvigorates CD8(+) effector T-cell function for synergistic cancer immunotherapy. ACS Cent Sci. 2025. https:\/\/doi.org\/10.1021\/acscentsci.5c00812.","journal-title":"ACS Cent Sci"},{"key":"10227_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.10.030","author":"D Arango","year":"2018","unstructured":"Arango D, et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell. 2018. https:\/\/doi.org\/10.1016\/j.cell.2018.10.030.","journal-title":"Cell"},{"key":"10227_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.05.016","author":"D Arango","year":"2022","unstructured":"Arango D, et al. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Mol Cell. 2022. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.016.","journal-title":"Mol Cell"},{"key":"10227_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03770-3","author":"G Balmus","year":"2018","unstructured":"Balmus G, et al. Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-03770-3.","journal-title":"Nat Commun"},{"key":"10227_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15870","author":"M Bei","year":"2023","unstructured":"Bei M, et al. Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m(6) A methylation. Cancer Sci. 2023. https:\/\/doi.org\/10.1111\/cas.15870.","journal-title":"Cancer Sci"},{"key":"10227_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2024.03.018","author":"H Beiki","year":"2024","unstructured":"Beiki H, et al. Detection of ac4C in human mRNA is preserved upon data reassessment. Mol Cell. 2024. https:\/\/doi.org\/10.1016\/j.molcel.2024.03.018.","journal-title":"Mol Cell"},{"key":"10227_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.06.005","author":"J Blagg","year":"2017","unstructured":"Blagg J, Workman P. Choose and use your chemical probe wisely to explore cancer biology. Cancer Cell. 2017. https:\/\/doi.org\/10.1016\/j.ccell.2017.06.005.","journal-title":"Cancer Cell"},{"key":"10227_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac404","author":"ML Bortolin-Cavaill\u00e9","year":"2022","unstructured":"Bortolin-Cavaill\u00e9 ML, et al. Probing small ribosomal subunit RNA helix 45 acetylation across eukaryotic evolution. Nucleic Acids Res. 2022. https:\/\/doi.org\/10.1093\/nar\/gkac404.","journal-title":"Nucleic Acids Res"},{"key":"10227_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2022.02.001","author":"M Broly","year":"2022","unstructured":"Broly M, et al. THUMPD1 bi-allelic variants cause loss of tRNA acetylation and a syndromic neurodevelopmental disorder. Am J Hum Genet. 2022. https:\/\/doi.org\/10.1016\/j.ajhg.2022.02.001.","journal-title":"Am J Hum Genet"},{"key":"10227_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.12.092","author":"S Cai","year":"2017","unstructured":"Cai S, Liu X, Zhang C, Xing B, Du X. Autoacetylation of NAT10 is critical for its function in rRNA transcription activation. Biochem Biophys Res Commun. 2017. https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.092.","journal-title":"Biochem Biophys Res Commun"},{"key":"10227_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05664-z","author":"T Cai","year":"2024","unstructured":"Cai T, et al. N-acetyltransferase 10 affects the proliferation of intrahepatic cholangiocarcinoma and M2-type polarization of macrophages by regulating C-C motif chemokine ligand 2. J Transl Med. 2024. https:\/\/doi.org\/10.1186\/s12967-024-05664-z.","journal-title":"J Transl Med"},{"key":"10227_CR14","doi-asserted-by":"publisher","DOI":"10.2174\/1566523223666230913110011","author":"M Ceccanti","year":"2024","unstructured":"Ceccanti M, Inghilleri M. RNA interference and neuromuscular diseases: a focus on hereditary transthyretin amyloidosis. Curr Gene Ther. 2024. https:\/\/doi.org\/10.2174\/1566523223666230913110011.","journal-title":"Curr Gene Ther"},{"key":"10227_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14209","author":"H Chen","year":"2019","unstructured":"Chen H, Xu Z, Liu D. Small non-coding RNA and colorectal cancer. J Cell Mol Med. 2019. https:\/\/doi.org\/10.1111\/jcmm.14209.","journal-title":"J Cell Mol Med"},{"key":"10227_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac594","author":"L Chen","year":"2022","unstructured":"Chen L, et al. NAT10-mediated N4-acetylcytidine modification is required for meiosis entry and progression in male germ cells. Nucleic Acids Res. 2022. https:\/\/doi.org\/10.1093\/nar\/gkac594.","journal-title":"Nucleic Acids Res"},{"key":"10227_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302705","author":"X Chen","year":"2023","unstructured":"Chen X, et al. NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer. Adv Sci (Weinh). 2023. https:\/\/doi.org\/10.1002\/advs.202302705.","journal-title":"Adv Sci (Weinh)"},{"key":"10227_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02089-6","author":"D Chen","year":"2024","unstructured":"Chen D, et al. Writers, readers, and erasers RNA modifications and drug resistance in cancer. Mol Cancer. 2024a. https:\/\/doi.org\/10.1186\/s12943-024-02089-6.","journal-title":"Mol Cancer"},{"key":"10227_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2024.11.188","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xue G, Hu Y, Da M. Exploring the role of NAT10 in regulating EMT and JAK2\/STAT3 pathway activation in cervical cancer progression. Asian J Surg. 2024b. https:\/\/doi.org\/10.1016\/j.asjsur.2024.11.188.","journal-title":"Asian J Surg"},{"key":"10227_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410263","author":"C Chen","year":"2025","unstructured":"Chen C, et al. NAT10 promotes gastric cancer liver metastasis by modulation of M2 macrophage polarization and metastatic tumor cell hepatic adhesion. Adv Sci (Weinh). 2025. https:\/\/doi.org\/10.1002\/advs.202410263.","journal-title":"Adv Sci (Weinh)"},{"key":"10227_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.06.032","author":"J Cheng","year":"2019","unstructured":"Cheng J, et al. Thermophile 90S pre-ribosome structures reveal the reverse order of co-transcriptional 18S rRNA subdomain Integration. Mol Cell. 2019. https:\/\/doi.org\/10.1016\/j.molcel.2019.06.032.","journal-title":"Mol Cell"},{"key":"10227_CR22","doi-asserted-by":"publisher","unstructured":"Chi YH, Haller K, Jr Peloponese JM, Jeang KT. Histone acetyltransferase hALP and nuclear membrane protein hsSUN1 function in de-condensation of mitotic chromosomes. J Biol Chem. 2007. https:\/\/doi.org\/10.1074\/jbc.M703098200.","DOI":"10.1074\/jbc.M703098200"},{"key":"10227_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84908-0","author":"MH Dalhat","year":"2021","unstructured":"Dalhat MH, Altayb HN, Khan MI, Choudhry H. Structural insights of human N-acetyltransferase 10 and identification of its potential novel inhibitors. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-84908-0.","journal-title":"Sci Rep"},{"key":"10227_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1045","author":"MH Dalhat","year":"2022","unstructured":"Dalhat MH, et al. NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells. Clin Transl Med. 2022. https:\/\/doi.org\/10.1002\/ctm2.1045.","journal-title":"Clin Transl Med"},{"key":"10227_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-02975-9","author":"MH Dalhat","year":"2024","unstructured":"Dalhat MH, Narayan S, Serio H, Arango D. Dissecting the oncogenic properties of essential RNA-modifying enzymes: a focus on NAT10. Oncogene. 2024. https:\/\/doi.org\/10.1038\/s41388-024-02975-9.","journal-title":"Oncogene"},{"key":"10227_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01350-23","author":"Y Dang","year":"2024","unstructured":"Dang Y, et al. N-acetyltransferase 10 regulates alphavirus replication via N4-acetylcytidine (ac4C) modification of the lymphocyte antigen six family member E (LY6E) mRNA. J Virol. 2024. https:\/\/doi.org\/10.1128\/jvi.01350-23.","journal-title":"J Virol"},{"key":"10227_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-025-05932-1","author":"J Deng","year":"2025","unstructured":"Deng J, Nong X, Yang G. N4-acetylcytidine-mediated SOAT1 upregulation aggravates heart failure by inducing NCOA4-dependent ferroautophagy and ferroptosis in cardiomyocytes. Cell Mol Life Sci. 2025. https:\/\/doi.org\/10.1007\/s00018-025-05932-1.","journal-title":"Cell Mol Life Sci"},{"key":"10227_CR28","doi-asserted-by":"publisher","DOI":"10.1515\/med-2022-0583","author":"C Du","year":"2022","unstructured":"Du C, et al. DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p\/NAT10 axis. Open Med. 2022. https:\/\/doi.org\/10.1515\/med-2022-0583.","journal-title":"Open Med"},{"key":"10227_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00957-5","author":"Y Fan","year":"2022","unstructured":"Fan Y, et al. Klotho in Osx(+)-mesenchymal progenitors exerts pro-osteogenic and anti-inflammatory effects during mandibular alveolar bone formation and repair. Signal Transduct Target Ther. 2022. https:\/\/doi.org\/10.1038\/s41392-022-00957-5.","journal-title":"Signal Transduct Target Ther"},{"key":"10227_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2410564121","author":"S Gao","year":"2024","unstructured":"Gao S, et al. N-acetyltransferase 10 mediates cognitive dysfunction through the acetylation of GABA(B)R1 mRNA in sepsis-associated encephalopathy. Proc Natl Acad Sci U S A. 2024. https:\/\/doi.org\/10.1073\/pnas.2410564121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10227_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0000000000002551","author":"K Gao","year":"2025","unstructured":"Gao K, et al. NAT10 promotes pyroptosis and pancreatic injury of severe acute pancreatitis through ac4C modification of NLRP3. Shock. 2025. https:\/\/doi.org\/10.1097\/shk.0000000000002551.","journal-title":"Shock"},{"key":"10227_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13577","author":"J Ge","year":"2024","unstructured":"Ge J, Wang Z, Wu J. NAT10-mediated ac(4)C modification promotes ectoderm differentiation of human embryonic stem cells via acetylating NR2F1 mRNA. Cell Prolif. 2024. https:\/\/doi.org\/10.1111\/cpr.13577.","journal-title":"Cell Prolif"},{"key":"10227_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03133-x","author":"S Gong","year":"2024","unstructured":"Gong S, et al. Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4\/ITGA6 translation. Oncogene. 2024. https:\/\/doi.org\/10.1038\/s41388-024-03133-x.","journal-title":"Oncogene"},{"key":"10227_CR34","doi-asserted-by":"publisher","unstructured":"Gu Z et al. The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression. MedComm 2020;2024. https:\/\/doi.org\/10.1002\/mco2.70026.","DOI":"10.1002\/mco2.70026"},{"key":"10227_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02162-0","author":"S Guerrero Llobet","year":"2022","unstructured":"Guerrero Llobet S, et al. An mRNA expression-based signature for oncogene-induced replication-stress. Oncogene. 2022. https:\/\/doi.org\/10.1038\/s41388-021-02162-0.","journal-title":"Oncogene"},{"key":"10227_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00842","author":"G Guo","year":"2020","unstructured":"Guo G, et al. Epitranscriptomic N4-acetylcytidine profiling in CD4(+) T cells of systemic lupus erythematosus. Front Cell Dev Biol. 2020. https:\/\/doi.org\/10.3389\/fcell.2020.00842.","journal-title":"Front Cell Dev Biol"},{"key":"10227_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2022.05.004","author":"XF Guo","year":"2022","unstructured":"Guo XF, et al. Elevation of N-acetyltransferase 10 in hippocampal neurons mediates depression- and anxiety-like behaviors. Brain Res Bull. 2022. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.05.004.","journal-title":"Brain Res Bull"},{"key":"10227_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.154","author":"Y Han","year":"2025","unstructured":"Han Y, et al. Biological function and mechanism of NAT10 in cancer. Cancer Innov. 2025. https:\/\/doi.org\/10.1002\/cai2.154.","journal-title":"Cancer Innov"},{"key":"10227_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac675","author":"H Hao","year":"2022","unstructured":"Hao H, et al. N4-acetylcytidine regulates the replication and pathogenicity of enterovirus 71. Nucleic Acids Res. 2022. https:\/\/doi.org\/10.1093\/nar\/gkac675.","journal-title":"Nucleic Acids Res"},{"key":"10227_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04454-4","author":"T Huang","year":"2025","unstructured":"Huang T, et al. The cytidine N-Acetyltransferase NAT10 promotes thalamus hemorrhage-induced central poststroke pain by stabilizing Fn14 expression in thalamic neurons. Mol Neurobiol. 2025a. https:\/\/doi.org\/10.1007\/s12035-024-04454-4.","journal-title":"Mol Neurobiol"},{"key":"10227_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107364","author":"M Huang","year":"2025","unstructured":"Huang M, Li J, Bai J, Du X, Xu J. NAT10 induces mitochondrial dysfunction in lung epithelial cells by acetylating HMGB1 to exacerbate Pseudomonas aeruginosa-induced acute lung injury. Microb Pathog. 2025b. https:\/\/doi.org\/10.1016\/j.micpath.2025.107364.","journal-title":"Microb Pathog"},{"key":"10227_CR42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C114.602698","author":"S Ito","year":"2014","unstructured":"Ito S, et al. Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA). J Biol Chem. 2014. https:\/\/doi.org\/10.1074\/jbc.C114.602698.","journal-title":"J Biol Chem"},{"key":"10227_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39256-0","author":"X Jiang","year":"2023","unstructured":"Jiang X, et al. Maternal NAT10 orchestrates oocyte meiotic cell-cycle progression and maturation in mice. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-39256-0.","journal-title":"Nat Commun"},{"key":"10227_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400133","author":"ZY Jiang","year":"2024","unstructured":"Jiang ZY, et al. PCBP1\/2 and TDP43 Function as NAT10 Adaptors to Mediate mRNA ac(4)C Formation in Mammalian Cells. Adv Sci (Weinh). 2024. https:\/\/doi.org\/10.1002\/advs.202400133.","journal-title":"Adv Sci (Weinh)"},{"key":"10227_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00286-3","author":"L Jiao","year":"2025","unstructured":"Jiao L, et al. Emerging role of N-acetyltransferase 10 in diseases: RNA ac4C modification and beyond. Mol Biomed. 2025. https:\/\/doi.org\/10.1186\/s43556-025-00286-3.","journal-title":"Mol Biomed"},{"key":"10227_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.01.037","author":"G Jin","year":"2020","unstructured":"Jin G, Xu M, Zou M, Duan S. The Processing, Gene Regulation, Biological Functions, and Clinical Relevance of N4-Acetylcytidine on RNA: A Systematic Review. Mol Ther Nucleic Acids. 2020. https:\/\/doi.org\/10.1016\/j.omtn.2020.01.037.","journal-title":"Mol Ther Nucleic Acids"},{"key":"10227_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02551-7","author":"C Jin","year":"2022","unstructured":"Jin C, et al. Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. J Exp Clin Cancer Res. 2022. https:\/\/doi.org\/10.1186\/s13046-022-02551-7.","journal-title":"J Exp Clin Cancer Res"},{"key":"10227_CR48","unstructured":"Kawai G, Hashizume T, Miyazawa T, McCloskey JA, Yokoyama S. Conformational characteristics of 4-acetylcytidine found in tRNA. Nucleic Acids Symp Ser. 1989."},{"key":"10227_CR49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.173393","author":"R Kong","year":"2011","unstructured":"Kong R, et al. hALP, a novel transcriptional U three protein (t-UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF). J Biol Chem. 2011. https:\/\/doi.org\/10.1074\/jbc.M110.173393.","journal-title":"J Biol Chem"},{"key":"10227_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00098-6","author":"P Kudrin","year":"2024","unstructured":"Kudrin P, Singh A, Meierhofer D, Ku\u015bnierczyk A, \u00d8rom UAV. N4-acetylcytidine (ac4C) promotes mRNA localization to stress granules. EMBO Rep. 2024. https:\/\/doi.org\/10.1038\/s44319-024-00098-6.","journal-title":"EMBO Rep"},{"key":"10227_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.01.009","author":"A Lachenmayer","year":"2012","unstructured":"Lachenmayer A, et al. Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. J Hepatol. 2012. https:\/\/doi.org\/10.1016\/j.jhep.2012.01.009.","journal-title":"J Hepatol"},{"key":"10227_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2025.108876","author":"NZE Lai","year":"2025","unstructured":"Lai NZE, Bashir ST, Ziv-Gal A, Sivagaru M, Nowak RA. Propylparaben negatively impacts IN VITRO preimplantation mouse embryo development. Reprod Toxicol. 2025. https:\/\/doi.org\/10.1016\/j.reprotox.2025.108876.","journal-title":"Reprod Toxicol"},{"key":"10227_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/science.1252651","author":"D Larrieu","year":"2014","unstructured":"Larrieu D, Britton S, Demir M, Rodriguez R, Jackson SP. Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science. 2014. https:\/\/doi.org\/10.1126\/science.1252651.","journal-title":"Science"},{"key":"10227_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2023.2274143","author":"Z Li","year":"2023","unstructured":"Li Z, Li D, Yang T, Yao C. NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA. Cancer Biol Ther. 2023. https:\/\/doi.org\/10.1080\/15384047.2023.2274143.","journal-title":"Cancer Biol Ther"},{"key":"10227_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2024.115495","author":"F Li","year":"2024","unstructured":"Li F, et al. GANSamples-ac4C: Enhancing ac4C site prediction via generative adversarial networks and transfer learning. Anal Biochem. 2024a. https:\/\/doi.org\/10.1016\/j.ab.2024.115495.","journal-title":"Anal Biochem"},{"key":"10227_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53350-x","author":"WP Li","year":"2024","unstructured":"Li WP, et al. N-acetyltransferase 10 is implicated in the pathogenesis of cycling T cell-mediated autoimmune and inflammatory disorders in mice. Nat Commun. 2024b. https:\/\/doi.org\/10.1038\/s41467-024-53350-x.","journal-title":"Nat Commun"},{"key":"10227_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70141","author":"J Li","year":"2024","unstructured":"Li J, Yushanjiang F, Fang Z, Liu WL. NAT10-mediated RNA ac4C acetylation contributes to the myocardial infarction-induced cardiac fibrosis. J Cell Mol Med. 2024c. https:\/\/doi.org\/10.1111\/jcmm.70141.","journal-title":"J Cell Mol Med"},{"key":"10227_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310131","author":"KJ Li","year":"2024","unstructured":"Li KJ, et al. NAT10 promotes prostate cancer growth and metastasis by acetylating mRNAs of HMGA1 and KRT8. Adv Sci (Weinh). 2024d. https:\/\/doi.org\/10.1002\/advs.202310131.","journal-title":"Adv Sci (Weinh)"},{"key":"10227_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03200-x","author":"G Li","year":"2024","unstructured":"Li G, et al. NAT10\/ac4C\/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction. J Exp Clin Cancer Res. 2024e. https:\/\/doi.org\/10.1186\/s13046-024-03200-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"10227_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01098-3","author":"D Li","year":"2025","unstructured":"Li D, et al. A novel human specific lncRNA MEK6-AS1 regulates adipogenesis and fatty acid biosynthesis by stabilizing MEK6 mRNA. J Biomed Sci. 2025a. https:\/\/doi.org\/10.1186\/s12929-024-01098-3.","journal-title":"J Biomed Sci"},{"key":"10227_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1695495","author":"C Li","year":"2025","unstructured":"Li C, et al. The critical role of NAT10-mediated N4-acetylcytidine modification in tumor immunity. Front Immunol. 2025b. https:\/\/doi.org\/10.3389\/fimmu.2025.1695495.","journal-title":"Front Immunol"},{"key":"10227_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00793-4","author":"L Liao","year":"2023","unstructured":"Liao L, et al. Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Res. 2023. https:\/\/doi.org\/10.1038\/s41422-023-00793-4.","journal-title":"Cell Res"},{"key":"10227_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-024-04250-5","author":"H Liao","year":"2024","unstructured":"Liao H, Ma H, Meng H, Kang N, Wang L. Ropinirole suppresses LPS-induced periodontal inflammation by inhibiting the NAT10 in an ac4C-dependent manner. BMC Oral Health. 2024. https:\/\/doi.org\/10.1186\/s12903-024-04250-5.","journal-title":"BMC Oral Health"},{"key":"10227_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01130-5","author":"L Liberale","year":"2025","unstructured":"Liberale L, et al. Roadmap for alleviating the manifestations of ageing in the cardiovascular system. Nat Rev Cardiol. 2025. https:\/\/doi.org\/10.1038\/s41569-025-01130-5.","journal-title":"Nat Rev Cardiol"},{"key":"10227_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.907286","author":"J Lin","year":"2022","unstructured":"Lin J, et al. NAT10 maintains OGA mRNA stability through ac4C modification in regulating oocyte maturation. Front Endocrinol (Lausanne). 2022. https:\/\/doi.org\/10.3389\/fendo.2022.907286.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10227_CR66","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201540505","author":"X Liu","year":"2016","unstructured":"Liu X, et al. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. EMBO Rep. 2016. https:\/\/doi.org\/10.15252\/embr.201540505.","journal-title":"EMBO Rep"},{"key":"10227_CR67","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky777","author":"X Liu","year":"2018","unstructured":"Liu X, et al. Deacetylation of NAT10 by Sirt1 promotes the transition from rRNA biogenesis to autophagy upon energy stress. Nucleic Acids Res. 2018. https:\/\/doi.org\/10.1093\/nar\/gky777.","journal-title":"Nucleic Acids Res"},{"key":"10227_CR68","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S197733","author":"Z Liu","year":"2019","unstructured":"Liu Z, et al. miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression. Cancer Manag Res. 2019. https:\/\/doi.org\/10.2147\/cmar.S197733.","journal-title":"Cancer Manag Res"},{"key":"10227_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa130","author":"HY Liu","year":"2020","unstructured":"Liu HY, et al. Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer. Nucleic Acids Res. 2020. https:\/\/doi.org\/10.1093\/nar\/gkaa130.","journal-title":"Nucleic Acids Res"},{"key":"10227_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad628","author":"R Liu","year":"2023","unstructured":"Liu R, et al. NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells. Nucleic Acids Res. 2023. https:\/\/doi.org\/10.1093\/nar\/gkad628.","journal-title":"Nucleic Acids Res"},{"key":"10227_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01777-5","author":"WW Liu","year":"2024","unstructured":"Liu WW, et al. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther. 2024a. https:\/\/doi.org\/10.1038\/s41392-024-01777-5.","journal-title":"Signal Transduct Target Ther"},{"key":"10227_CR72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-4062","author":"S Liu","year":"2024","unstructured":"Liu S, et al. NAT10 phase separation regulates YTHDF1 splicing to promote gastric cancer progression. Cancer Res. 2024b. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-4062.","journal-title":"Cancer Res"},{"key":"10227_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00228-5","author":"J Liu","year":"2024","unstructured":"Liu J, et al. Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8(+) T cell activity in prostate cancer. Mol Biomed. 2024c. https:\/\/doi.org\/10.1186\/s43556-024-00228-5.","journal-title":"Mol Biomed"},{"key":"10227_CR74","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225343","author":"D Liu","year":"2024","unstructured":"Liu D, et al. NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritis. Ann Rheum Dis. 2024d. https:\/\/doi.org\/10.1136\/ard-2023-225343.","journal-title":"Ann Rheum Dis"},{"key":"10227_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03185-z","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. m(6)A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation. Oncogene. 2024e. https:\/\/doi.org\/10.1038\/s41388-024-03185-z.","journal-title":"Oncogene"},{"key":"10227_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12595","author":"H Liu","year":"2024","unstructured":"Liu H, et al. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Cancer Commun (Lond). 2024f. https:\/\/doi.org\/10.1002\/cac2.12595.","journal-title":"Cancer Commun (Lond)"},{"key":"10227_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2024.112447","author":"N Liu","year":"2025","unstructured":"Liu N, et al. NAT10 drives endometriosis progression through acetylation and stabilization of TGFB1 mRNA. Mol Cell Endocrinol. 2025a. https:\/\/doi.org\/10.1016\/j.mce.2024.112447.","journal-title":"Mol Cell Endocrinol"},{"key":"10227_CR78","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2025.2555779","author":"H Liu","year":"2025","unstructured":"Liu H, Zhang X, Lu Q, Zhang H. NAT10 contributes to the progression of multiple myeloma through ac4C modification of GPR37. Hematology. 2025b. https:\/\/doi.org\/10.1080\/16078454.2025.2555779.","journal-title":"Hematology"},{"key":"10227_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60293-4","author":"WC Liu","year":"2025","unstructured":"Liu WC, et al. Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC\/CDK2\/DNMT1 pathway. Nat Commun. 2025c. https:\/\/doi.org\/10.1038\/s41467-025-60293-4.","journal-title":"Nat Commun"},{"key":"10227_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115628","author":"J Luo","year":"2023","unstructured":"Luo J, Cao J, Chen C, Xie H. Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challenges. Biochem Pharmacol. 2023. https:\/\/doi.org\/10.1016\/j.bcp.2023.115628.","journal-title":"Biochem Pharmacol"},{"key":"10227_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.09.235","author":"J Lv","year":"2003","unstructured":"Lv J, et al. Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochem Biophys Res Commun. 2003. https:\/\/doi.org\/10.1016\/j.bbrc.2003.09.235.","journal-title":"Biochem Biophys Res Commun"},{"key":"10227_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126573","author":"N Ma","year":"2022","unstructured":"Ma N, Liu H, Wu Y, Yao M, Zhang B. Inhibition of N-acetyltransferase 10 suppresses the progression of prostate cancer through regulation of DNA replication. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23126573.","journal-title":"Int J Mol Sci"},{"key":"10227_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae262","author":"CR Ma","year":"2024","unstructured":"Ma CR, Liu N, Li H, Xu H, Zhou XL. Activity reconstitution of Kre33 and Tan1 reveals a molecular ruler mechanism in eukaryotic tRNA acetylation. Nucleic Acids Res. 2024a. https:\/\/doi.org\/10.1093\/nar\/gkae262.","journal-title":"Nucleic Acids Res"},{"key":"10227_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46458-7","author":"W Ma","year":"2024","unstructured":"Ma W, et al. N-Acetyltransferase 10 represses Uqcr11 and Uqcrb independently of ac4C modification to promote heart regeneration. Nat Commun. 2024b. https:\/\/doi.org\/10.1038\/s41467-024-46458-7.","journal-title":"Nat Commun"},{"key":"10227_CR85","doi-asserted-by":"publisher","DOI":"10.2174\/0113892029296712240405053201","author":"R Mehmood","year":"2024","unstructured":"Mehmood R. Ramifications of m6A Modification on ncRNAs in Cancer. Curr Genomics. 2024. https:\/\/doi.org\/10.2174\/0113892029296712240405053201.","journal-title":"Curr Genomics"},{"key":"10227_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01321-y","author":"Z Mei","year":"2024","unstructured":"Mei Z, et al. NAT10 mediated ac4C acetylation driven m(6)A modification via involvement of YTHDC1-LDHA\/PFKM regulates glycolysis and promotes osteosarcoma. Cell Commun Signal. 2024. https:\/\/doi.org\/10.1186\/s12964-023-01321-y.","journal-title":"Cell Commun Signal"},{"key":"10227_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31474","author":"Y Mo","year":"2025","unstructured":"Mo Y, et al. NAT10 functions as a pivotal regulator in gastric cancer metastasis and tumor immunity. J Cell Physiol. 2025a. https:\/\/doi.org\/10.1002\/jcp.31474.","journal-title":"J Cell Physiol"},{"key":"10227_CR88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2423991122","author":"X Mo","year":"2025","unstructured":"Mo X, et al. Nat10-mediated N4-acetylcytidine modification enhances Nfatc1 translation to exacerbate osteoclastogenesis in postmenopausal osteoporosis. Proc Natl Acad Sci U S A. 2025b. https:\/\/doi.org\/10.1073\/pnas.2423991122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10227_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.10.035","author":"HF Noller","year":"2024","unstructured":"Noller HF. The ribosome comes to life. Cell. 2024. https:\/\/doi.org\/10.1016\/j.cell.2024.10.035.","journal-title":"Cell"},{"key":"10227_CR90","unstructured":"Oashi Z, et al. Characterization of C + located in the first position of the anticodon of Escherichia coli tRNA Met as N 4 -acetylcytidine. Biochim Biophys Acta. 1972."},{"key":"10227_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0142-8","author":"JS O'Donnell","year":"2019","unstructured":"O\u2019Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 2019. https:\/\/doi.org\/10.1038\/s41571-018-0142-8.","journal-title":"Nat Rev Clin Oncol"},{"key":"10227_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-022-00501-9","author":"EA Orellana","year":"2022","unstructured":"Orellana EA, Siegal E, Gregory RI. tRNA dysregulation and disease. Nat Rev Genet. 2022. https:\/\/doi.org\/10.1038\/s41576-022-00501-9.","journal-title":"Nat Rev Genet"},{"key":"10227_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00780-4","author":"G Qin","year":"2024","unstructured":"Qin G, et al. Targeting the NAT10\/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy. Mol Med. 2024. https:\/\/doi.org\/10.1186\/s10020-024-00780-4.","journal-title":"Mol Med"},{"key":"10227_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1623276","author":"D Qin","year":"2025","unstructured":"Qin D, et al. Research progress on NAT10-mediated acetylation in normal development and disease. Front Cell Dev Biol. 2025. https:\/\/doi.org\/10.3389\/fcell.2025.1623276.","journal-title":"Front Cell Dev Biol"},{"key":"10227_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103145","author":"Z Qu","year":"2024","unstructured":"Qu Z, et al. The positive feedback loop of the NAT10\/Mybbp1a\/p53 axis promotes cardiomyocyte ferroptosis to exacerbate cardiac I\/R injury. Redox Biol. 2024. https:\/\/doi.org\/10.1016\/j.redox.2024.103145.","journal-title":"Redox Biol"},{"key":"10227_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154990","author":"P Rodrigues","year":"2024","unstructured":"Rodrigues P, et al. The mechanistic role of NAT10 in cancer: unraveling the enigmatic web of oncogenic signaling. Pathol Res Pract. 2024. https:\/\/doi.org\/10.1016\/j.prp.2023.154990.","journal-title":"Pathol Res Pract"},{"key":"10227_CR97","doi-asserted-by":"publisher","DOI":"10.1261\/rna.079948.124","author":"S Schiffers","year":"2024","unstructured":"Schiffers S, Oberdoerffer S. ac4C: a fragile modification with stabilizing functions in RNA metabolism. RNA. 2024. https:\/\/doi.org\/10.1261\/rna.079948.124.","journal-title":"RNA"},{"key":"10227_CR98","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv075","author":"S Sharma","year":"2015","unstructured":"Sharma S, et al. Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1\/THUMPD1. Nucleic Acids Res. 2015. https:\/\/doi.org\/10.1093\/nar\/gkv075.","journal-title":"Nucleic Acids Res"},{"key":"10227_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006804","author":"S Sharma","year":"2017","unstructured":"Sharma S, et al. Specialized box C\/D snoRNPs act as antisense guides to target RNA base acetylation. PLoS Genet. 2017. https:\/\/doi.org\/10.1371\/journal.pgen.1006804.","journal-title":"PLoS Genet"},{"key":"10227_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2009.03.007","author":"Q Shen","year":"2009","unstructured":"Shen Q, et al. NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp Cell Res. 2009. https:\/\/doi.org\/10.1016\/j.yexcr.2009.03.007.","journal-title":"Exp Cell Res"},{"key":"10227_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24573","author":"J Shen","year":"2024","unstructured":"Shen J, Sun Y, Zhuang Q, Xue D, He X. NAT10 promotes renal ischemia-reperfusion injury via activating NCOA4-mediated ferroptosis. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24573.","journal-title":"Heliyon"},{"key":"10227_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2023.121149","author":"W Shenshen","year":"2023","unstructured":"Shenshen W, et al. NAT10 accelerates pulmonary fibrosis through N4-acetylated TGFB1-initiated epithelial-to-mesenchymal transition upon ambient fine particulate matter exposure. Environ Pollut. 2023. https:\/\/doi.org\/10.1016\/j.envpol.2023.121149.","journal-title":"Environ Pollut"},{"key":"10227_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01577-6","author":"L Shi","year":"2026","unstructured":"Shi L, et al. NAT10 regulates heart development and function by maintaining the expression of genes related to fatty acid \u03b2-oxidation and heart contraction. Cell Death Differ. 2026. https:\/\/doi.org\/10.1038\/s41418-025-01577-6.","journal-title":"Cell Death Differ"},{"key":"10227_CR104","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429387340250507055903","author":"F Shibagaki","year":"2024","unstructured":"Shibagaki F, Hayashi Y, Matsumoto S, Nakamichi N. Ergothioneine suppresses amyloid \u03b2-Induced tau phosphorylation and cytotoxicity by inactivating glycogen synthase kinase-3\u03b2 in cultured neurons. Curr Mol Pharmacol. 2024. https:\/\/doi.org\/10.2174\/0118761429387340250507055903.","journal-title":"Curr Mol Pharmacol"},{"key":"10227_CR105","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00193","author":"JH Shrimp","year":"2021","unstructured":"Shrimp JH, et al. Remodelin Is a cryptic assay interference chemotype that does not inhibit NAT10-dependent cytidine acetylation. ACS Med Chem Lett. 2021. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00193.","journal-title":"ACS Med Chem Lett"},{"key":"10227_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06373-z","author":"Y Shuai","year":"2024","unstructured":"Shuai Y, et al. CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression. Cell Death Dis. 2024. https:\/\/doi.org\/10.1038\/s41419-023-06373-z.","journal-title":"Cell Death Dis"},{"key":"10227_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091035","author":"S Sleiman","year":"2019","unstructured":"Sleiman S, Dragon F. Recent advances on the structure and function of RNA acetyltransferase Kre33\/NAT10. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8091035.","journal-title":"Cells"},{"key":"10227_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101858","author":"D Sturgill","year":"2022","unstructured":"Sturgill D, Arango D, Oberdoerffer S. Protocol for base resolution mapping of ac4C using RedaC:T-seq. STAR Protoc. 2022. https:\/\/doi.org\/10.1016\/j.xpro.2022.101858.","journal-title":"STAR Protoc"},{"key":"10227_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01869-3","author":"K Su","year":"2024","unstructured":"Su K, et al. NAT10 resolves harmful nucleolar R-loops depending on its helicase domain and acetylation of DDX21. Cell Commun Signal. 2024. https:\/\/doi.org\/10.1186\/s12964-024-01869-3.","journal-title":"Cell Commun Signal"},{"key":"10227_CR110","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae263","author":"Z Sun","year":"2024","unstructured":"Sun Z, et al. Acetylation-ubiquitination crosstalk of DJ-1 mediates microcalcification formation in diabetic plaques via collagen-matrix vesicles interaction. Cardiovasc Res. 2024. https:\/\/doi.org\/10.1093\/cvr\/cvae263.","journal-title":"Cardiovasc Res"},{"key":"10227_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.04.047","author":"Y Tan","year":"2018","unstructured":"Tan Y, et al. Loss of nucleolar localization of NAT10 promotes cell migration and invasion in hepatocellular carcinoma. Biochem Biophys Res Commun. 2018. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.047.","journal-title":"Biochem Biophys Res Commun"},{"key":"10227_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00501-9","author":"S ThalallaGamage","year":"2021","unstructured":"ThalallaGamage S, Sas-Chen A, Schwartz S, Meier JL. Quantitative nucleotide resolution profiling of RNA cytidine acetylation by ac4C-seq. Nat Protoc. 2021. https:\/\/doi.org\/10.1038\/s41596-021-00501-9.","journal-title":"Nat Protoc"},{"key":"10227_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2019.02.022","author":"JM Thomas","year":"2019","unstructured":"Thomas JM, Bryson KM, Meier JL. Nucleotide resolution sequencing of N4-acetylcytidine in RNA. Methods Enzymol. 2019. https:\/\/doi.org\/10.1016\/bs.mie.2019.02.022.","journal-title":"Methods Enzymol"},{"key":"10227_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.05.011","author":"K Tsai","year":"2020","unstructured":"Tsai K, et al. Acetylation of cytidine residues boosts HIV-1 gene expression by increasing viral RNA stability. Cell Host Microbe. 2020. https:\/\/doi.org\/10.1016\/j.chom.2020.05.011.","journal-title":"Cell Host Microbe"},{"key":"10227_CR115","doi-asserted-by":"publisher","unstructured":"Uhl\u00e9n M, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015. https:\/\/doi.org\/10.1126\/science.1260419.","DOI":"10.1126\/science.1260419"},{"key":"10227_CR116","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad226","author":"T ValizadehAslani","year":"2023","unstructured":"ValizadehAslani T, et al. PharmBERT: a domain-specific BERT model for drug labels. Brief Bioinform. 2023. https:\/\/doi.org\/10.1093\/bib\/bbad226.","journal-title":"Brief Bioinform"},{"key":"10227_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.10.028","author":"T Wang","year":"2019","unstructured":"Wang T, Zou Y, Huang N, Teng J, Chen J. CCDC84 acetylation oscillation regulates centrosome duplication by modulating HsSAS-6 degradation. Cell Rep. 2019. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.028.","journal-title":"Cell Rep"},{"key":"10227_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202106058","author":"K Wang","year":"2022","unstructured":"Wang K, et al. PIWI-interacting RNA HAAPIR regulates cardiomyocyte death after myocardial infarction by promoting NAT10-Mediated ac(4) C acetylation of Tfec mRNA. Adv Sci (Weinh). 2022a. https:\/\/doi.org\/10.1002\/advs.202106058.","journal-title":"Adv Sci (Weinh)"},{"key":"10227_CR119","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01736-6","author":"Z Wang","year":"2022","unstructured":"Wang Z, et al. c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer. Med Oncol. 2022b. https:\/\/doi.org\/10.1007\/s12032-022-01736-6.","journal-title":"Med Oncol"},{"key":"10227_CR120","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04955-w","author":"M Wang","year":"2023","unstructured":"Wang M, et al. N(4)-acetylcytidine of Nop2 mRNA is required for the transition of morula-to-blastocyst. Cell Mol Life Sci. 2023a. https:\/\/doi.org\/10.1007\/s00018-023-04955-w.","journal-title":"Cell Mol Life Sci"},{"key":"10227_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121948","author":"C Wang","year":"2023","unstructured":"Wang C, et al. Targeting NAT10 protects against sepsis-induced skeletal muscle atrophy by inhibiting ROS\/NLRP3. Life Sci. 2023b. https:\/\/doi.org\/10.1016\/j.lfs.2023.121948.","journal-title":"Life Sci"},{"key":"10227_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127789","author":"L Wang","year":"2024","unstructured":"Wang L, et al. The emerging roles of ac4C acetylation \u201cwriter\u201d NAT10 in tumorigenesis: a comprehensive review. Int J Biol Macromol. 2024a. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127789.","journal-title":"Int J Biol Macromol"},{"key":"10227_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06951-9","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma. Cell Death Dis. 2024b. https:\/\/doi.org\/10.1038\/s41419-024-06951-9.","journal-title":"Cell Death Dis"},{"key":"10227_CR124","doi-asserted-by":"publisher","DOI":"10.1007\/s13353-024-00840-9","author":"S Wang","year":"2024","unstructured":"Wang S, et al. Peptidylprolyl isomerase D circular RNA sensitizes breast cancer to trastuzumab through remodeling HER2 N4-acetylcytidine modification. J Appl Genet. 2024c. https:\/\/doi.org\/10.1007\/s13353-024-00840-9.","journal-title":"J Appl Genet"},{"key":"10227_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01306-8","author":"XX Wang","year":"2024","unstructured":"Wang XX, et al. Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction. Acta Pharmacol Sin. 2024d. https:\/\/doi.org\/10.1038\/s41401-024-01306-8.","journal-title":"Acta Pharmacol Sin"},{"key":"10227_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01997-2","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53\/IRF1\/type I interferon signaling axis. Cell Death Discov. 2024e. https:\/\/doi.org\/10.1038\/s41420-024-01997-2.","journal-title":"Cell Death Discov"},{"key":"10227_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02360-1","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. NAT10 promotes liver lipogenesis in mouse through N4-acetylcytidine modification of Srebf1 and Scap mRNA. Lipids Health Dis. 2024f. https:\/\/doi.org\/10.1186\/s12944-024-02360-1.","journal-title":"Lipids Health Dis"},{"key":"10227_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1448890","author":"L Wang","year":"2024","unstructured":"Wang L, et al. Acetylcytidine modification of DDX41 and ZNF746 by N-acetyltransferase 10 contributes to chemoresistance of melanoma. Front Oncol. 2024g. https:\/\/doi.org\/10.3389\/fonc.2024.1448890.","journal-title":"Front Oncol"},{"key":"10227_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-025-01504-9","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. The function of NAT10-driven N4-acetylcytidine modification in cancer: novel insights and potential therapeutic targets. Cell Biosci. 2025a. https:\/\/doi.org\/10.1186\/s13578-025-01504-9.","journal-title":"Cell Biosci"},{"key":"10227_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111918","author":"Z Wang","year":"2025","unstructured":"Wang Z, et al. Oxidative stress promotes intervertebral disc degeneration through NAT10-mediated IKK\u03b2 N4-acetylcytidine modification. Cell Signal. 2025b. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111918.","journal-title":"Cell Signal"},{"key":"10227_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-02059-6","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Integrating single-cell RNA and T cell\/B cell receptor sequencing with mass cytometry reveals dynamic trajectories of human peripheral immune cells from birth to old age. Nat Immunol. 2025c. https:\/\/doi.org\/10.1038\/s41590-024-02059-6.","journal-title":"Nat Immunol"},{"key":"10227_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2026.112441","author":"T Wang","year":"2026","unstructured":"Wang T, et al. GNE-493 suppresses gastric cancer development by targeting NAT10-mediated ac4C modification of HK2. Cell Signal. 2026. https:\/\/doi.org\/10.1016\/j.cellsig.2026.112441.","journal-title":"Cell Signal"},{"key":"10227_CR133","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae822","author":"T Warwick","year":"2025","unstructured":"Warwick T, Kurian L, Brandes RP. Acetylation alchemy: how Nat10 shapes vascular health. Eur Heart J. 2025. https:\/\/doi.org\/10.1093\/eurheartj\/ehae822.","journal-title":"Eur Heart J"},{"key":"10227_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.01.015","author":"R Wei","year":"2022","unstructured":"Wei R, et al. NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma. Acta Pharm Sin b. 2022. https:\/\/doi.org\/10.1016\/j.apsb.2022.01.015.","journal-title":"Acta Pharm Sin b"},{"key":"10227_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1575391","author":"Z Wei","year":"2025","unstructured":"Wei Z, Lv Z, Zhang W. Emodin inhibits colon cancer tumor growth by suppressing tumor cell glycolysis through inhibition of NAT10-mediated PGK1 ac4C modification. Front Oncol. 2025a. https:\/\/doi.org\/10.3389\/fonc.2025.1575391.","journal-title":"Front Oncol"},{"key":"10227_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101229","author":"JR Wei","year":"2025","unstructured":"Wei JR, et al. Overcoming cancer therapy resistance: From drug innovation to therapeutics. Drug Resist Updat. 2025b. https:\/\/doi.org\/10.1016\/j.drup.2025.101229.","journal-title":"Drug Resist Updat"},{"key":"10227_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.749171","author":"KX Wu","year":"2021","unstructured":"Wu KX, et al. LncRNA-ENST00000421645 upregulates Kank1 to Inhibit IFN-\u03b3 expression and promote T cell apoptosis in neurosyphilis. Front Microbiol. 2021. https:\/\/doi.org\/10.3389\/fmicb.2021.749171.","journal-title":"Front Microbiol"},{"key":"10227_CR138","unstructured":"Wu J, Zhu H, Wu J, Chen W, Guan X. Inhibition of N-acetyltransferase 10 using remodelin attenuates doxorubicin resistance by reversing the epithelial-mesenchymal transition in breast cancer. Am J Transl Res. 2018."},{"key":"10227_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.12.002","author":"Z Wu","year":"2024","unstructured":"Wu Z, Zhang W, Qu J, Liu GH. Emerging epigenetic insights into aging mechanisms and interventions. Trends Pharmacol Sci. 2024. https:\/\/doi.org\/10.1016\/j.tips.2023.12.002.","journal-title":"Trends Pharmacol Sci"},{"key":"10227_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118191","author":"D Xiao","year":"2024","unstructured":"Xiao D, et al. Mijiao formula regulates NAT10-mediated Runx2 mRNA ac4C modification to promote bone marrow mesenchymal stem cell osteogenic differentiation and improve osteoporosis in ovariectomized rats. J Ethnopharmacol. 2024a. https:\/\/doi.org\/10.1016\/j.jep.2024.118191.","journal-title":"J Ethnopharmacol"},{"key":"10227_CR141","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-024-09962-6","author":"B Xiao","year":"2024","unstructured":"Xiao B, et al. Advances of NAT10 in diseases: insights from dual properties as protein and RNA acetyltransferase. Cell Biol Toxicol. 2024b. https:\/\/doi.org\/10.1007\/s10565-024-09962-6.","journal-title":"Cell Biol Toxicol"},{"key":"10227_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.139823","author":"N Xiao","year":"2025","unstructured":"Xiao N, et al. N-acetyltransferase 10 impedes EZH2\/H3K27me3\/GABARAP axis mediated autophagy and facilitates lung cancer tumorigenesis through enhancing SGK2 mRNA acetylation. Int J Biol Macromol. 2025. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.139823.","journal-title":"Int J Biol Macromol"},{"key":"10227_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.03.023","author":"L Xie","year":"2023","unstructured":"Xie L, et al. Mechanisms of NAT10 as ac4C writer in diseases. Mol Ther Nucleic Acids. 2023a. https:\/\/doi.org\/10.1016\/j.omtn.2023.03.023.","journal-title":"Mol Ther Nucleic Acids"},{"key":"10227_CR144","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-2233","author":"R Xie","year":"2023","unstructured":"Xie R, et al. NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Res. 2023b. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2233.","journal-title":"Cancer Res"},{"key":"10227_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00912-w","author":"P Xing","year":"2024","unstructured":"Xing P, et al. NAT10-mediated ac(4)C acetylation of TFRC promotes sepsis-induced pulmonary injury through regulating ferroptosis. Mol Med. 2024. https:\/\/doi.org\/10.1186\/s10020-024-00912-w.","journal-title":"Mol Med"},{"key":"10227_CR146","doi-asserted-by":"publisher","DOI":"10.1007\/s42764-021-00046-x","author":"C Xu","year":"2021","unstructured":"Xu C, Zhang J, Zhang J, Liu B. SIRT7 is a deacetylase of N4-acetylcytidine on ribosomal RNA. Genome Instab Dis. 2021. https:\/\/doi.org\/10.1007\/s42764-021-00046-x.","journal-title":"Genome Instab Dis"},{"key":"10227_CR147","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303113","author":"T Xu","year":"2023","unstructured":"Xu T, et al. Ac4C enhances the translation efficiency of Vegfa mRNA and mediates central sensitization in spinal dorsal horn in neuropathic pain. Adv Sci (Weinh). 2023. https:\/\/doi.org\/10.1002\/advs.202303113.","journal-title":"Adv Sci (Weinh)"},{"key":"10227_CR148","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.124.035714","author":"T Xu","year":"2024","unstructured":"Xu T, et al. Loss of NAT10 Reduces the Translation of Kmt5a mRNA Through ac4C Modification in Cardiomyocytes and Induces Heart Failure. J Am Heart Assoc. 2024. https:\/\/doi.org\/10.1161\/jaha.124.035714.","journal-title":"J Am Heart Assoc"},{"key":"10227_CR149","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16249","author":"Z Xue","year":"2024","unstructured":"Xue Z, et al. NAT10 inhibition promotes ac4C-dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. Cancer Sci. 2024. https:\/\/doi.org\/10.1111\/cas.16249.","journal-title":"Cancer Sci"},{"key":"10227_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42135-3","author":"Q Yan","year":"2023","unstructured":"Yan Q, et al. NAT10-dependent N(4)-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-42135-3.","journal-title":"Nat Commun"},{"key":"10227_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01327-0","author":"Q Yan","year":"2024","unstructured":"Yan Q, et al. Lactylation of NAT10 promotes N(4)-acetylcytidine modification on tRNA(Ser-CGA-1-1) to boost oncogenic DNA virus KSHV reactivation. Cell Death Differ. 2024. https:\/\/doi.org\/10.1038\/s41418-024-01327-0.","journal-title":"Cell Death Differ"},{"key":"10227_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.06.022","author":"W Yang","year":"2021","unstructured":"Yang W, et al. ac4C acetylation of RUNX2 catalyzed by NAT10 spurs osteogenesis of BMSCs and prevents ovariectomy-induced bone loss. Mol Ther Nucleic Acids. 2021. https:\/\/doi.org\/10.1016\/j.omtn.2021.06.022.","journal-title":"Mol Ther Nucleic Acids"},{"key":"10227_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300898","author":"Q Yang","year":"2023","unstructured":"Yang Q, et al. N4-acetylcytidine drives glycolysis addiction in gastric cancer via NAT10\/SEPT9\/HIF-1\u03b1 positive feedback loop. Adv Sci (Weinh). 2023. https:\/\/doi.org\/10.1002\/advs.202300898.","journal-title":"Adv Sci (Weinh)"},{"key":"10227_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102030","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10. Mol Metab. 2024. https:\/\/doi.org\/10.1016\/j.molmet.2024.102030.","journal-title":"Mol Metab"},{"key":"10227_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.07.031","author":"R Yang","year":"2025","unstructured":"Yang R, et al. NAT10 promotes osteoclastogenesis in inflammatory bone loss by catalyzing Fos mRNA ac4C modification and upregulating MAPK signaling pathway. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2024.07.031.","journal-title":"J Adv Res"},{"key":"10227_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2025.168961","author":"L Yao","year":"2025","unstructured":"Yao L, et al. Caps-ac4C: an effective computational framework for identifying N4-acetylcytidine sites in human mRNA based on deep learning. J Mol Biol. 2025. https:\/\/doi.org\/10.1016\/j.jmb.2025.168961.","journal-title":"J Mol Biol"},{"key":"10227_CR157","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-024-10579-7","author":"W Yin","year":"2024","unstructured":"Yin W, Wang J, Li L, Zheng H, Xu S. NAT10 modulates atherosclerosis progression mediated by macrophage polarization through regulating ac4C modification of TLR9. J Cardiovasc Transl Res. 2024. https:\/\/doi.org\/10.1007\/s12265-024-10579-7.","journal-title":"J Cardiovasc Transl Res"},{"key":"10227_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02628-3","author":"XM Yu","year":"2023","unstructured":"Yu XM, et al. N4-acetylcytidine modification of lncRNA CTC-490G23.2 promotes cancer metastasis through interacting with PTBP1 to increase CD44 alternative splicing. Oncogene. 2023. https:\/\/doi.org\/10.1038\/s41388-023-02628-3.","journal-title":"Oncogene"},{"key":"10227_CR159","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae707","author":"C Yu","year":"2025","unstructured":"Yu C, et al. NAT10 promotes vascular remodelling via mRNA ac4C acetylation. Eur Heart J. 2025. https:\/\/doi.org\/10.1093\/eurheartj\/ehae707.","journal-title":"Eur Heart J"},{"key":"10227_CR160","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz545","author":"L Zhang","year":"2019","unstructured":"Zhang L, Li DQ. MORC2 regulates DNA damage response through a PARP1-dependent pathway. Nucleic Acids Res. 2019. https:\/\/doi.org\/10.1093\/nar\/gkz545.","journal-title":"Nucleic Acids Res"},{"key":"10227_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00489-4","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduct Target Ther. 2021. https:\/\/doi.org\/10.1038\/s41392-021-00489-4.","journal-title":"Signal Transduct Target Ther"},{"key":"10227_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03868-x","author":"H Zhang","year":"2022","unstructured":"Zhang H, et al. NAT10 regulates neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and activating STING pathway. Commun Biol. 2022a. https:\/\/doi.org\/10.1038\/s42003-022-03868-x.","journal-title":"Commun Biol"},{"key":"10227_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.967811","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. NAT10 acetylates BCL-XL mRNA to promote the proliferation of multiple myeloma cells through PI3K-AKT pathway. Front Oncol. 2022b. https:\/\/doi.org\/10.3389\/fonc.2022.967811.","journal-title":"Front Oncol"},{"key":"10227_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00853-9","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Visualizing the nucleoplasmic maturation of human pre-60S ribosomal particles. Cell Res. 2023a. https:\/\/doi.org\/10.1038\/s41422-023-00853-9.","journal-title":"Cell Res"},{"key":"10227_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17103","author":"W Zhang","year":"2023","unstructured":"Zhang W, et al. ac4C acetylation regulates mRNA stability and translation efficiency in osteosarcoma. Heliyon. 2023b. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17103.","journal-title":"Heliyon"},{"key":"10227_CR166","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.2321-22.2023","author":"M Zhang","year":"2023","unstructured":"Zhang M, et al. The cytidine N-Acetyltransferase NAT10 participates in peripheral nerve injury-induced neuropathic pain by stabilizing SYT9 expression in primary sensory neurons. J Neurosci. 2023c. https:\/\/doi.org\/10.1523\/jneurosci.2321-22.2023.","journal-title":"J Neurosci"},{"key":"10227_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01417-5","author":"S Zhang","year":"2024","unstructured":"Zhang S, et al. Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression. Cell Commun Signal. 2024a. https:\/\/doi.org\/10.1186\/s12964-023-01417-5.","journal-title":"Cell Commun Signal"},{"key":"10227_CR168","doi-asserted-by":"publisher","DOI":"10.2174\/0113894501346709241202110834","author":"W Zhang","year":"2024","unstructured":"Zhang W, et al. Emerging Role of NAT10 as ac4C Writer in Inflammatory Diseases: Mechanisms and Therapeutic Applications. Curr Drug Targets. 2024b. https:\/\/doi.org\/10.2174\/0113894501346709241202110834.","journal-title":"Curr Drug Targets"},{"key":"10227_CR169","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00540-6","author":"C Zhang","year":"2024","unstructured":"Zhang C, et al. CircMAST1 inhibits cervical cancer progression by hindering the N4-acetylcytidine modification of YAP mRNA. Cell Mol Biol Lett. 2024c. https:\/\/doi.org\/10.1186\/s11658-024-00540-6.","journal-title":"Cell Mol Biol Lett"},{"key":"10227_CR170","doi-asserted-by":"publisher","DOI":"10.1002\/oby.24041","author":"QR Zhang","year":"2024","unstructured":"Zhang QR, et al. Loss of NAT10 alleviates maternal high-fat diet-induced hepatic steatosis in male offspring of mice. Obesity (Silver Spring). 2024d. https:\/\/doi.org\/10.1002\/oby.24041.","journal-title":"Obesity (Silver Spring)"},{"key":"10227_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.119324","author":"W Zhang","year":"2025","unstructured":"Zhang W, et al. Polyethylene microplastics transported to nucleus pulposus cells via macrophages-derived exosomes, and promote intervertebral disc degeneration through NAT10\/SLC7A11 and ac4C modification. Ecotoxicol Environ Saf. 2025a. https:\/\/doi.org\/10.1016\/j.ecoenv.2025.119324.","journal-title":"Ecotoxicol Environ Saf"},{"key":"10227_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/exp.20250075","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. Targeting NAT10 inhibits hepatocarcinogenesis via ac4C-mediated SMAD3 mRNA stability. Exploration (Beijing). 2025b. https:\/\/doi.org\/10.1002\/exp.20250075.","journal-title":"Exploration (Beijing)"},{"key":"10227_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03434-4","author":"K Zhang","year":"2025","unstructured":"Zhang K, et al. Artificial intelligence in drug development. Nat Med. 2025c. https:\/\/doi.org\/10.1038\/s41591-024-03434-4.","journal-title":"Nat Med"},{"key":"10227_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47594-7","author":"W Zhao","year":"2019","unstructured":"Zhao W, Zhou Y, Cui Q, Zhou Y. PACES: prediction of N4-acetylcytidine (ac4C) modification sites in mRNA. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-019-47594-7.","journal-title":"Sci Rep"},{"key":"10227_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00899-5","author":"J Zheng","year":"2022","unstructured":"Zheng J, et al. NAT10 regulates mitotic cell fate by acetylating Eg5 to control bipolar spindle assembly and chromosome segregation. Cell Death Differ. 2022a. https:\/\/doi.org\/10.1038\/s41418-021-00899-5.","journal-title":"Cell Death Differ"},{"key":"10227_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12363","author":"X Zheng","year":"2022","unstructured":"Zheng X, et al. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun (Lond). 2022b. https:\/\/doi.org\/10.1002\/cac2.12363.","journal-title":"Cancer Commun (Lond)"},{"key":"10227_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03277-y","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, et al. EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor remodelin in colorectal cancer. J Exp Clin Cancer Res. 2025. https:\/\/doi.org\/10.1186\/s13046-025-03277-y.","journal-title":"J Exp Clin Cancer Res"},{"key":"10227_CR178","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-025-10081-z","author":"J Zhou","year":"2025","unstructured":"Zhou J, et al. NAT10 mediates cardiac fibrosis induced by myocardial infarction through ac4C modification of TGFBR1 mRNA. Cell Biol Toxicol. 2025. https:\/\/doi.org\/10.1007\/s10565-025-10081-z.","journal-title":"Cell Biol Toxicol"},{"key":"10227_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-74222-6","author":"M Zhou","year":"2026","unstructured":"Zhou M, et al. Structure of the NAT10 acetyltransferase and mechanism of tRNA acetylation. Nat Commun. 2026. https:\/\/doi.org\/10.1038\/s41467-026-74222-6.","journal-title":"Nat Commun"},{"key":"10227_CR180","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8833527","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Xing X, Huang S, Tu Y. NAT10 promotes osteogenic differentiation of mesenchymal stem cells by mediating N4-acetylcytidine modification of Gremlin 1. Stem Cells Int. 2021. https:\/\/doi.org\/10.1155\/2021\/8833527.","journal-title":"Stem Cells Int"},{"key":"10227_CR181","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202510854","author":"J Zhu","year":"2026","unstructured":"Zhu J, et al. Reprogramming tumor-associated macrophages via targeted NAT10 inhibition to enhance colorectal cancer immunotherapy. Adv Sci (Weinh). 2026. https:\/\/doi.org\/10.1002\/advs.202510854.","journal-title":"Adv Sci (Weinh)"},{"key":"10227_CR182","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060664","author":"S Zhuang","year":"2024","unstructured":"Zhuang S, et al. Can O-GIcNAc Transferase (OGT) complex be used as a target for the treatment of hematological malignancies? Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17060664.","journal-title":"Pharmaceuticals (Basel)"},{"key":"10227_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101728","author":"Y Zou","year":"2024","unstructured":"Zou Y, et al. Targeting NAT10 inhibits osteosarcoma progression via ATF4\/ASNS-mediated asparagine biosynthesis. Cell Rep Med. 2024. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101728.","journal-title":"Cell Rep Med"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10227-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:55:58Z","timestamp":1791510958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10227-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":183,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10227"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10227-7","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to publication of the present manuscript.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"116"}}